Bonesupport Holding

BONEX · Nasdaq Stockholm · SEK

230,00 krVariazione rispetto alla chiusura precedente: +3,32%Variazione assoluta: +7,40 kr

Chiusura · 5 ottobre 2026

Profilo dell'azienda

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Descrizione disponibile in inglese.

Dati societari

Settore
Salute
Industria
Medical Instruments & Supplies
Paese
Svezia
Sede
Scheelevägen 19, 223 70, Lund
Dipendenti
171
Quotazione
BONEX · Nasdaq Stockholm
Valuta
SEK
ISIN
SE0009858152